Global Viral Clearance Service Market Growth (Status and Outlook) 2023-2029

Global Viral Clearance Service Market Growth (Status and Outlook) 2023-2029

Product Code:456829

Published Date: Feb 08,2023

Pages: 102

Region: Global

Category: Medical Care

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

Viral clearance services refer to viral removal or viral inactivation service. Viral clearance studies are a critical element toward ensuring that an acceptable level of viral safety has been achieved for biological products. The goal of these studies is to demonstrate that the manufacturing purification process has the ability to inactivate and/or remove viruses that are known to contaminate or which may possibly contaminate the starting materials, as well as additional viruses that are models for a broad variety of viruses. Viral clearance studies provide a complementary strategy to direct testing of cell banks, raw materials and bioreactor harvests, which may not detect all viruses that could potentially contaminate the product.

LPI (LP Information)' newest research report, the “Viral Clearance Service Industry Forecast” looks at past sales and reviews total world Viral Clearance Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Viral Clearance Service sales for 2023 through 2029. With Viral Clearance Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Viral Clearance Service industry.

This Insight Report provides a comprehensive analysis of the global Viral Clearance Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Viral Clearance Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Viral Clearance Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Viral Clearance Service and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Viral Clearance Service.

The global Viral Clearance Service market size is projected to grow from US$ 399.2 million in 2022 to US$ 1364.4 million in 2029; it is expected to grow at a CAGR of 19.2% from 2023 to 2029.

North America is the largest Viral Clearance Service market with about 51% market share. Europe is follower, accounting for about 23% market share.The key manufacturers are Charles River, BioReliance (Merck), Eurofins Scientific, Sartorius, Covance, ViruSure, Texcell, Bioscience Labs, Vironova Biosafety, Mérieux NutriSciences, WuXi AppTec, Syngene, Labor Dr. Merk etc. Top 3 companies occupied about 39% market share.

This report presents a comprehensive overview, market shares, and growth opportunities of Viral Clearance Service market by product type, application, key players and key regions and countries.

Market Segmentation:
Segmentation by type
    Basic Service
    Enhanced Service
    Full Service
    Turnkey Service

Segmentation by application
    Research Institution
    Pharmaceutical Industry
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Charles River
    BioReliance (Merck)
    Eurofins Scientific
    Sartorius
    Covance
    ViruSure
    Texcell
    Bioscience Labs
    Vironova Biosafety
    Mérieux NutriSciences
    WuXi AppTec
    Syngene
    Labor Dr. Merk